FCCC LOGO Faculty Publications
Adelstein D , Gillison ML , Pfister DG , Spencer S , Adkins D , Brizel DM , Burtness B , Busse PM , Caudell JJ , Cmelak AJ , Colevas AD , Eisele DW , Fenton M , Foote RL , Gilbert J , Haddad RI , Hicks WL Jr , Hitchcock YJ , Jimeno A , Leizman D , Lydiatt WM , Maghami E , Mell LK , Mittal BB , Pinto HA , Ridge JA , Rocco J , Rodriguez CP , Shah JP , Weber RS , Witek M , Worden F , Yom SS , Zhen W , Burns JL , Darlow SD
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
J Natl Compr Canc Netw. 2017 Jun;15(6) :761-770
Back to previous list
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.
Notes
1540-1413 Adelstein, David Gillison, Maura L Pfister, David G Spencer, Sharon Adkins, Douglas Brizel, David M Burtness, Barbara Busse, Paul M Caudell, Jimmy J Cmelak, Anthony J Colevas, A Dimitrios Eisele, David W Fenton, Moon Foote, Robert L Gilbert, Jill Haddad, Robert I Hicks, Wesley L Jr Hitchcock, Ying J Jimeno, Antonio Leizman, Debra Lydiatt, William M Maghami, Ellie Mell, Loren K Mittal, Bharat B Pinto, Harlan A Ridge, John A Rocco, James Rodriguez, Cristina P Shah, Jatin P Weber, Randal S Witek, Matthew Worden, Frank Yom, Sue S Zhen, Weining Burns, Jennifer L Darlow, Susan D Journal Article United States J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.